| Date Filed | Type | Description |
| 09/20/2022 |
SC 13D
| ARCH Venture Fund VIII, L.P. reports a 24.7% stake in Codiak Biosciences, Inc. |
| 09/15/2022 |
4
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Bought 5,000,000 shares
@ $1.5, valued at
$7.5M
Bought 5,000,000 warrants
@ $1.875, valued at
$9.4M
|
|
| 02/08/2022 |
SC 13G/A
| ARCH Venture Fund VIII, L.P. has filed a Schedule 13D for Exit Filing)* Denali Therapeutics Inc. |
| 02/04/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2021 |
SC 13G
| ARCH Venture Fund VIII, L.P. has filed a Schedule 13D for * Metacrine, Inc. |
| 02/02/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2020 |
3
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 3 on Metacrine, Inc. |
| 02/13/2020 |
SC 13G/A
| ARCH Venture Fund VIII, L.P. reports a 8.9% stake in Scholar Rock Holding Corporation |
| 02/13/2020 |
SC 13G/A
| ARCH Venture Fund VIII, L.P. reports a 11.1% stake in Denali Therapeutics Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2019 |
4
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Disposed of 300,001 shares
@ $0 |
|
| 03/06/2019 |
SC 13D
| ARCH Venture Fund VIII, L.P. reports a 19.9% stake in Sienna Biopharmaceuticals, Inc. |
| 02/26/2019 |
4
| ARCH Venture Partners VIII, LLC (10% Owner) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Bought 150,000 shares
@ $2.5, valued at
$375k
Bought 1,865,800 shares
@ $2.5, valued at
$4.7M
|
|
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G
| ARCH Venture Fund VIII, L.P. reports a 10.5% stake in Scholar Rock Holding Corporation |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/31/2018 |
4
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp|
Txns:
| Converted 437,859 shares
@ $0
Converted 634,579 shares
@ $0
Converted 551,807 shares
@ $0
Converted 719,559 shares
@ $0
Converted 293,813 shares
@ $0
Converted 1,249,999 options to buy
@ $0
Converted 1,811,595 options to buy
@ $0
Converted 1,575,299 options to buy
@ $0
Converted 2,054,197 options to buy
@ $0
Converted 838,780 options to buy
@ $0 |
|
| 05/23/2018 |
3
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 3 on Scholar Rock Holding Corp |
| 04/04/2018 |
4
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Converted 6,068,695 shares
@ $0
Converted 4,683,238 preferred shares
@ $0
Converted 1,385,457 preferred shares
@ $0 |
|
| 03/27/2018 |
3
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 3 on Homology Medicines, Inc. |
| 02/02/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2018 |
SC 13G
| ARCH Venture Fund VIII, L.P. reports a 12.3% stake in Denali Therapeutics Inc. |
| 12/12/2017 |
4
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Converted 10,756,249 shares
@ $0
Converted 10,068,749 preferred shares
@ $0
Converted 375,000 preferred shares
@ $0
Converted 312,500 preferred shares
@ $0 |
|
| 12/07/2017 |
3
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 3 on Denali Therapeutics Inc. |
| 07/26/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2016 |
SC 13G/A
| ARCH Venture Fund VIII, L.P. reports a 8.8% stake in Kura Oncology, Inc. |
| 03/13/2015 |
SC 13G
| ARCH Venture Fund VIII, L.P. reports a 9.3% stake in Kura Oncology, Inc. |